EcoDrugPlus

Protein Farnesyltransferase Subunit Beta-Like

Ensembl ID : ENSPREG00000010309
Gene Symbol: LOC103457641
3 Cross references
209 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSPREG00000000241
Gene Symbol: PRKCA
3 Cross references
213 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSPREG00000019286
Gene Symbol: PRKCB
4 Cross references
207 Possible Orthologues:

Protein Kinase C Beta Type-Like

Ensembl ID : ENSPREG00000000386
Gene Symbol: LOC103462977
3 Cross references
223 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSPREG00000017949
Gene Symbol: PRKCD
3 Cross references
203 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSPREG00000012364
Gene Symbol: PRKCD
3 Cross references
204 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSPREG00000006435
Gene Symbol: PRKCE
4 Cross references
246 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSPREG00000004923
Gene Symbol: PRKCE
2 Cross references
249 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSPREG00000015569
Gene Symbol: PRKCH
3 Cross references
223 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSPREG00000013611
Gene Symbol: PRKCI
3 Cross references
87 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSPREG00000018319
Gene Symbol: PRKCQ
3 Cross references
204 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSPREG00000006532
Gene Symbol: PRKCZ
3 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).